Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey A Schneier

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Review of Gastroenterology & Hepatology|December 14, 2011
Clarification of trial end points presented in a recent review of linaclotideJeffrey M Johnston, Harvey A Schneier
The American Journal of Gastroenterology|November 8, 2017
Response to Miner et alMark G Currie, Steven J Shiff, Harvey A Schneier, et al.
The American Journal of Gastroenterology|September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationSatish Rao, Anthony J Lembo, Steven J Shiff, et al.
The American Journal of Gastroenterology|September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safetyWilliam D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Review of Gastroenterology & Hepatology|December 14, 2011
Clarification of trial end points presented in a recent review of linaclotideJeffrey M Johnston, Harvey A Schneier
The American Journal of Gastroenterology|November 8, 2017
Response to Miner et alMark G Currie, Steven J Shiff, Harvey A Schneier, et al.
The American Journal of Gastroenterology|September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationSatish Rao, Anthony J Lembo, Steven J Shiff, et al.
The American Journal of Gastroenterology|September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safetyWilliam D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Pageof 1